OCUGEN, INC. Operating Cash Flow
OCUGEN, INC. (OCGN) reported Operating Cash Flow of -$33.99 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- OCUGEN, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$12.20M.
- OCUGEN, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$21.79M.
- OCUGEN, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$13.96M.
- OCUGEN, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$12.92M.
- OCUGEN, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$56.96M.
- OCUGEN, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$42.14M.
- OCUGEN, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$62.05M.
- OCUGEN, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$60.08M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$12.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$33.99M 10-Q · filed 2026-08-06 | -$47.95M derived: sum of 3 quarters · filed 2026-08-06 | -$60.87M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$21.79M 10-Q · filed 2026-05-08 | -$35.76M derived: sum of 2 quarters · filed 2026-05-08 | -$48.67M derived: sum of 3 quarters · filed 2026-05-08 | -$59.40M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$13.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$26.88M derived: sum of 2 quarters · filed 2026-03-04 | -$37.61M derived: sum of 3 quarters · filed 2026-08-06 | -$56.96M 10-K · filed 2026-03-04 | ||||
| 2025-09-30 | -$12.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$23.65M derived: sum of 2 quarters · filed 2026-08-06 | -$43.00M 10-Q · filed 2025-11-05 | -$53.37M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$10.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$30.09M 10-Q · filed 2026-08-06 | -$40.45M derived: sum of 3 quarters · filed 2026-08-06 | -$51.72M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$19.36M 10-Q · filed 2026-05-08 | -$29.72M derived: sum of 2 quarters · filed 2026-05-08 | -$40.99M derived: sum of 3 quarters · filed 2026-05-08 | -$50.90M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | -$10.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$21.64M derived: sum of 2 quarters · filed 2026-03-04 | -$31.55M derived: sum of 3 quarters · filed 2026-03-04 | -$42.14M 10-K · filed 2026-03-04 | ||||
| 2024-09-30 | -$11.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$21.18M derived: sum of 2 quarters · filed 2025-11-05 | -$31.78M 10-Q · filed 2025-11-05 | -$43.08M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | -$9.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$20.51M 10-Q · filed 2025-08-04 | -$31.81M derived: sum of 3 quarters · filed 2025-08-04 | -$45.51M derived: sum of 4 quarters · filed 2025-08-04 | ||||
| 2024-03-31 | -$10.60M 10-Q · filed 2025-05-09 | -$21.90M derived: sum of 2 quarters · filed 2025-05-09 | -$35.60M derived: sum of 3 quarters · filed 2025-05-09 | -$54.41M derived: sum of 4 quarters · filed 2025-05-09 | ||||
| 2023-12-31 | -$11.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | -$25.01M derived: sum of 2 quarters · filed 2025-03-05 | -$43.81M derived: sum of 3 quarters · filed 2025-03-05 | -$62.05M 10-K · filed 2025-03-05 | ||||
| 2023-09-30 | -$13.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$32.51M derived: sum of 2 quarters · filed 2024-11-14 | -$50.75M 10-Q · filed 2024-11-14 | -$67.67M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$18.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$37.05M 10-Q · filed 2024-08-08 | -$53.96M derived: sum of 3 quarters · filed 2024-08-08 | -$68.26M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$18.24M 10-Q · filed 2024-05-14 | -$35.15M derived: sum of 2 quarters · filed 2024-05-14 | -$49.46M derived: sum of 3 quarters · filed 2024-05-14 | -$63.25M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | -$16.91M derived: 10-K 12 month − 10-K 9 month · filed 2024-04-16 | -$31.22M derived: sum of 2 quarters · filed 2024-04-16 | -$45.01M derived: sum of 3 quarters · filed 2024-04-16 | -$60.08M 10-K · filed 2024-04-16 | ||||
| 2022-09-30 | -$14.30M derived: 10-K 9 month − 10-K 6 month · filed 2024-04-16 | -$28.10M derived: sum of 2 quarters · filed 2024-04-16 | -$43.16M 10-K · filed 2024-04-16 | -$55.97M derived: sum of 4 quarters · filed 2024-04-16 | ||||
| 2022-06-30 | -$13.80M derived: 10-K 6 month − 10-K 3 month · filed 2024-04-16 | -$28.86M 10-K · filed 2024-04-16 | -$41.67M derived: sum of 3 quarters · filed 2024-04-16 | -$49.72M derived: sum of 4 quarters · filed 2024-04-16 | ||||
| 2022-03-31 | -$15.07M 10-K · filed 2024-04-16 | -$27.87M derived: sum of 2 quarters · filed 2024-04-16 | -$35.92M derived: sum of 3 quarters · filed 2024-04-16 | -$57.72M derived: sum of 4 quarters · filed 2024-04-16 | ||||
| 2021-12-31 | -$12.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$20.86M derived: sum of 2 quarters · filed 2023-02-28 | -$42.66M derived: sum of 3 quarters · filed 2023-02-28 | -$47.94M 10-K · filed 2023-02-28 | ||||
| 2021-09-30 | -$8.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$29.85M derived: sum of 2 quarters · filed 2022-11-08 | -$35.14M 10-Q · filed 2022-11-08 | -$39.42M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | -$21.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$27.08M 10-Q · filed 2022-08-05 | -$31.37M derived: sum of 3 quarters · filed 2022-08-05 | -$34.02M derived: sum of 4 quarters · filed 2022-08-05 | ||||
| 2021-03-31 | -$5.28M 10-Q · filed 2022-05-06 | -$9.57M derived: sum of 2 quarters · filed 2022-05-06 | -$12.22M derived: sum of 3 quarters · filed 2022-05-06 | -$15.31M derived: sum of 4 quarters · filed 2022-05-06 | ||||
| 2020-12-31 | -$4.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$6.94M derived: sum of 2 quarters · filed 2022-02-28 | -$10.02M derived: sum of 3 quarters · filed 2022-02-28 | -$14.71M 10-K · filed 2022-02-28 | -$14.71M 10-K · filed 2021-03-19 | |||
| 2020-09-30 | -$2.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$5.74M derived: sum of 2 quarters · filed 2021-11-09 | -$10.43M 10-Q · filed 2021-11-09 | -$10.43M 10-Q · filed 2020-11-06 | -$19.17M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-06-30 | -$3.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$7.77M 10-Q · filed 2021-08-06 | -$7.77M 10-Q · filed 2020-08-14 | -$16.52M derived: sum of 3 quarters · filed 2022-02-28 | -$18.64M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | -$4.69M 10-Q · filed 2021-05-07 | -$4.69M 10-Q · filed 2020-05-08 | -$13.43M derived: sum of 2 quarters · filed 2022-02-28 | -$15.55M derived: sum of 3 quarters · filed 2022-02-28 | -$18.91M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | -$8.74M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$10.86M derived: sum of 2 quarters · filed 2022-02-28 | -$14.23M derived: sum of 3 quarters · filed 2022-02-28 | -$16.89M 10-K · filed 2022-02-28 | -$16.89M 10-K · filed 2020-03-27 | |||
| 2019-09-30 | -$2.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$5.48M derived: sum of 2 quarters · filed 2020-11-06 | -$8.15M 10-Q · filed 2020-11-06 | -$10.94M derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | -$3.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$6.03M 10-Q · filed 2020-08-14 | -$11.55M 10-Q · filed 2019-08-09 | -$8.82M derived: sum of 3 quarters · filed 2020-08-14 | -$11.90M derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2019-03-31 | -$2.67M 10-Q · filed 2020-05-08 | -$8.49M 10-Q · filed 2019-05-15 | -$5.45M derived: sum of 2 quarters · filed 2020-05-08 | -$8.53M derived: sum of 3 quarters · filed 2020-05-08 | -$17.58M derived: sum of 4 quarters · filed 2020-05-08 | |||
| 2018-12-31 | -$2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$5.87M derived: sum of 2 quarters · filed 2020-03-27 | -$14.92M derived: sum of 3 quarters · filed 2020-03-27 | -$11.63M 10-K · filed 2020-03-27 | -$15.78M 10-K · filed 2019-03-22 | |||
| 2018-09-30 | -$3.08M derived: 10-Q 9 month − 8-K/A 6 month · filed 2019-11-12 | -$12.13M derived: sum of 2 quarters · filed 2019-11-12 | -$8.84M 10-Q · filed 2019-11-12 | -$8.84M 10-Q · filed 2018-11-08 | -$13.16M derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2018-06-30 | -$9.05M derived: 8-K/A 6 month − 10-Q 3 month · filed 2019-10-07 | -$5.76M 8-K/A · filed 2019-10-07 | -$1.93M 10-Q · filed 2018-08-09 | -$10.08M derived: sum of 3 quarters · filed 2019-10-07 | -$15.81M derived: sum of 4 quarters · filed 2019-10-07 | |||
| 2018-03-31 | $3.29M 10-Q · filed 2019-05-15 | -$1.03M derived: sum of 2 quarters · filed 2019-05-15 | -$6.76M derived: sum of 3 quarters · filed 2019-05-15 | |||||
| 2017-12-31 | -$4.32M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | -$10.05M derived: sum of 2 quarters · filed 2019-03-22 | -$23.02M 10-K · filed 2019-03-22 | |||||
| 2017-09-30 | -$5.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$18.70M 10-Q · filed 2018-11-08 | ||||||
| 2017-06-30 | -$12.97M 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |